| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SMARCA5_0006500 | Exon-Exon | chr4:144464662-144468061 | chr4:143543509-143546908 | 149 nt | 0.3893 |
| hsa_SMARCA5_0006600 | Exon-Exon | chr4:144464662-144468656 | chr4:143543509-143547503 | 388 nt | 0.3969 |
| hsa_SMARCA5_0006700 | Exon-Exon | chr4:144464662-144469293 | chr4:143543509-143548140 | 155 nt | 0.3935 |
| hsa_SMARCA5_0006800 | Exon-Exon | chr4:144464662-144471257 | chr4:143543509-143550104 | 114 nt | 0.4123 |
| hsa_SMARCA5_0006900 | Exon-Exon | chr4:144464666-144465125 | chr4:143543513-143543972 | 265 nt | 0.3736 |
| hsa_SMARCA5_0007000 | Exon-Exon | chr4:144464754-144465125 | chr4:143543601-143543972 | 177 nt | 0.3729 |
| hsa_SMARCA5_0007100 | Exon-Exon | chr4:144465890-144468656 | chr4:143544737-143547503 | 252 nt | 0.3889 |
| hsa_SMARCA5_0007200 | Exon-Exon | chr4:144465890-144471257 | chr4:143544737-143550104 | 111 nt | 0.4324 |
| hsa_SMARCA5_0007300 | Exon-Exon | chr4:144465964-144467200 | chr4:143544811-143546047 | 123 nt | 0.4065 |
| hsa_SMARCA5_0007400 | Exon-Exon | chr4:144466623-144467200 | chr4:143545470-143546047 | 237 nt | 0.3924 |
A study in mice demonstrated that the circSMARCA5 promotes angiogenesis by sponging SRSF1 mRNA to regulate VEGF-A [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. A study in human bloodstains demonstrated that the circSMARCA5 exhibited linear degradation over 120 days, with its relative expression negatively correlated with bloodstain age both indoors (r=0.81) and outdoors (r=0.91), and it was incorporated into a mathematical formula for estimating the time since deposition [Wei et al. DOI:10.1016/j.forsciint.2022.111408]. A separate review noted that in human plasma, the circSMARCA5 is lower in patients with more severe coronary atherosclerosis, with an AUC of 0.589, indicating its potential as a diagnostic biomarker for stable coronary artery disease [Tian et al. DOI:10.3390/molecules26041155].